MedPath

Comparison of the Platelet-rich plasma and hyaluronic acid injections in treatment of knee osteoarthritis

Phase 3
Recruiting
Conditions
Osteoarthritis.
Polyosteoarthritis, unspecified
Registration Number
IRCT20180129038548N1
Lead Sponsor
Vice Chancellor for Research and Technology of Babol University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
81
Inclusion Criteria

Patients with diagnosis of bilateral knee osteoarthritis based on American college of Rheumatology.
Morning stiffness lasting less than 30 minutes
Radiographic evidence of osteoarthritis
Symptoms lasting at least 3 months

Exclusion Criteria

Other knee joint diseases, like rheumatoid arthritis and gout.
Intra-articular knee joint corticosteroid injection over the past two weeks

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Change in Western Ontario & McMaster Universities Osteoarthritis Index (WOMAC) pain sub-scale. Timepoint: Weeks 4, 8 and 12 of treatment. Method of measurement: Based on Western Ontario & McMaster Universities Osteoarthritis Index (WOMAC) and Visual Analogue Scale (VAS).
Secondary Outcome Measures
NameTimeMethod
Change in global Western Ontario & McMaster Universities Osteoarthritis Index (WOMAC). Timepoint: Weeks 4, 8 and 12 of treatment. Method of measurement: Based on Western Ontario & McMaster Universities Osteoarthritis Index (WOMAC).
© Copyright 2025. All Rights Reserved by MedPath